Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07257094 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Site details revised at 1 of 9 sitesv4
  2. Minor Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised at 2 of 9 sites
    v3
  3. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
    • Primary and study completion dates: Jun 30, 2027 to Jul 30, 2027
    • Start date changed from estimate of Jan 15, 2026 to Jan 10, 2026
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description revised
    • Site details revised at 9 of 9 sites
    • Eligibility criteria shortened, about 3 words
  4. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to validate a French version of the Nasal Reconstruction FACE-Q questionnaire for patients who have undergone nasal reconstruction or prosthetic rehabilitation after surgery for nasal skin cancer. The questionnaire evaluates appearance, quality of life, and possible side effects related to the reconstruction. The investigators hypothesize that the validated French version will provide a reliable and standardized tool to assess patient satisfaction and health-related quality of life in this context.
Trial Details
NCT Number NCT07257094
Lead Sponsor Hôpital NOVO
Conditions
(from sponsor)
Carcinoma
Related terms Basal Cell Carcinoma, Carcinoma, Carcinoma, Squamous Cell
Enrollment 346 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov